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correlations between ADL-Q and cognitive screening measures among patients with dementia. This
study examined the relationship between ADL-Q and the Montreal Cognitive Assessment (MoCA), a
brief cognitive screening.
Methods: Records of 448 individuals from an outpatient neurology clinic were reviewed. Pearson
correlations were calculated between ADL-Q scores and MoCA scores. Linear regression models
were fit using demographic information to predict ADL-Q scores. MoCA scores were then added
to the models to determine the increase in predictive value of the MoCA.
Results: Lower MoCA scores were associated with higher levels of functional impairment. For each
model, adding the MoCA significantly improved model fit.
Discussion: Low scores on the MoCA, among patient’s presenting for memory complaints, should
raise concerns about functional decline and prompt for further assessment of functional ability.
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4.0/).Keywords: Activities of daily living questionnaire; Montreal cognitive assessment; Cognitive screening; Activities of dailyliving1. Introduction
Impairments in basic and instrumental activities of daily
living (ADL) are often associated with cognitive decline in
elderly populations. Measuring an individual’s functioning
in ADLs is an important aspect of assessment for neurode-
generative disease and is necessary in making accurate di-
agnoses, evaluating the severity of disease, monitoring
disease progression over time, and ensuring appropriate
levels of support are in place. Clinicians often use brief
cognitive screening tests (e.g., Montreal Cognitive Assess-
ment, Mini-Mental Status Examination) and measures of
ADLs as part of routine dementia evaluations, and under-
standing how such measures are related is important touthor. Tel.: 11-702-701-7960; Fax: 11-702-483-
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he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).establish how performance on cognitive screening may be
predictive of functional independence and establish the
need for further testing.
Research comparing performance on brief cognitive
screening tests and measures of ADLs has demonstrated
that individuals with greater cognitive impairment are
more likely to have functional impairments in ADLs
(e.g., [1,2]). In the dementia process, ADLs are typically
lost in a hierarchical manner, with instrumental ADLs
being impacted before basic ADLs [3,4]. Although
performing ADLs involves multiple cognitive processes,
research suggests that levels of executive functioning
may be particularly important in predicting levels of
functional impairment [5].
Given variable levels of insight among individuals with
neurodegenerative disease, assessment of functional inde-
pendence often uses collateral reports. One exampleimer’s Association. This is an open access article under the CC BY-NC-ND
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mental ADLs is the Activities of Daily Living Question-
naire (ADL-Q [6]), which provides an overall indication
of functional independence, as well as, more specific
assessment of targeted domains (e.g., self-care, household
care, employment and recreation, shopping and money,
travel, and communication). Johnson et al. [6] examined
its relationship with the mini-mental state examination
(MMSE [7]) and the Clinical Dementia Rating Scale [8]
and showed that individuals with lower scores on the
cognitive screening measures had greater levels of func-
tional impairment in ADLs.
The Montreal Cognitive Assessment (MoCA [9]) has
been increasingly adopted as a cognitive screening tool
given its increased sensitivity over other cognitive
screening tools and its inclusion of cognitive domains
not assessed by other screening measures (e.g., executive
functioning) [10–12]. Given that the MoCA is a new
measure that has not been included in most research
associating functional impairment with cognition, it is
valuable to examine the MoCA’s relationship to the
ADL-Q to ensure a similar trend holds true. The inclusion
of executive functioning on the MoCA may increase its
sensitivity to functional decline. This study sought to
ascertain the relationship between performance on the
MoCA and informant reports of functional independence
using the ADL-Q in a memory disordered population
because both are freely available measures that could be
readily used in clinical settings.2. Method
2.1. Participants
Data were obtained from medical records of 448
consecutive patients seen by neuropsychology in an
outpatient neurology center specializing in neurodegener-
ative disease. Patients with Parkinson’s disease (PD) were
excluded to limit the influence of motor impairments on
functional status. All other patients referred for neuropsy-
chological testing were included. The analyzed sample
was 47.3% women and predominately Caucasian
(91.5%) with an average age of 71.3 years (SD 5 8.9),
an average of 14.5 years (SD 5 2.8) of education, and
average estimated premorbid intelligence of 99.1
(SD 5 13.9). Working diagnostic considerations included
Alzheimer Disease (n 5 115), mild cognitive impairment
(n 5 91), cognitive disorder not otherwise specified
(n 5 72), psychiatric illness including depression and
anxiety (PSY, n 5 18), dementia with Lewy bodies
(n 5 17), frontotemporal dementia (n 5 12), cognitively
normal (Normal; n 5 12), vascular dementia (n 5 6),
and other neurological conditions including hydrocepha-
lus, primary progressive aphasia, post concussive syn-
drome, seizures, stroke, cognitive impairment due to an
acute medical illness, and subjective memory complaints(Other; n 5 26). Diagnostic information was unavailable
for 79 individuals. The MoCA was completed during the
initial visit with neurology, and subsequent neuropsycho-
logical assessment included a standard battery of cogni-
tive measures. A family member or caregiver completed
an inventory rating functional independence. This study
was reviewed and approved by the Cleveland Clinic Insti-
tutional Review Board.2.2. Measures2.2.1. Activities of Daily Living Questionnaire
The ADL-Q is an informant report questionnaire
completed by a caregiver and is divided into six domains
of functioning as follows: (1) self-care, (2) household
care, (3) employment/recreation, (4) shopping/money,
(5) travel, and (6) communication. Each domain contains
three to six items rated using a 4-point scale, ranging
from zero (no problem) to 3 (no longer capable). An op-
tion to indicate the individual never performed the activ-
ity in the past, stopped the activity before illness, or the
rater does not have sufficient knowledge to rate func-
tioning in that area is also available; if endorsed, this
item is not counted. A total score representing overall
functional impairment and subscale scores representing
functional impairment in each of the six areas are calcu-
lated. Total scores ranging from 0%–33% indicate mini-
mal impairment, 34%–66% moderate impairment, and
67% severe impairment.
2.2.2. Montreal Cognitive Assessment
The MoCA is a brief cognitive screening measure that
takes approximately 10 minutes to administer and can be
administered by various levels of health care providers.
The MoCA consists of 12 individual tasks grouped into
cognitive domains including (1) visuospatial/executive func-
tioning, (2) naming, (3) attention, (4) language, (5) abstrac-
tion, (6) memory, and (7) orientation. A total score is
calculated, and an educational correction is made if appli-
cable (i.e., one point added for individuals with 12 years
of education or less). Validated clinical use of the MoCA
is interpretation of the total score, with a total score of
26 indicating cognitive impairment.2.3. Data analysis
Pearson correlation coefficients were calculated to deter-
mine the relationship between ADL-Q scores and MoCA to-
tal scores. Several linear regression models were first fit
using age, gender, education, and estimated premorbid intel-
ligence as predictors in a base model. Outcomes of interest
included separate models for the ADL-Q total score, as
well as, the individual ADL-Q domain scores, for a total
of seven separate models. The MoCA total score was then
added to each base model to determine the added predictive
Table 2
Effect of adding MoCA total score as a predictor of ADL-Q scores
ADL-Q domain R2 R2 change MoCA b 95% CI
Total 0.134 0.121 20.38 21.72 21.03
Self-care 0.098 0.093 20.33 21.11 20.61
Household care 0.083 0.046 20.23 21.94 20.80
Employment/recreation 0.044 0.042 20.22 21.60 20.61
Shopping/money 0.138 0.132 20.39 23.10 21.90
Travel 0.089 0.069 20.28 22.10 21.03
Communication 0.165 0.119 20.37 21.76 21.06
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mographics. Model performance was evaluated by the
change in R2 values from adding the MoCA and inspecting
standardized regression coefficients of each predictor. To
evaluate cognitive domains most strongly related to func-
tional impairment, another regression was fit using the
same base model and then adding the individual MoCA
domain scores as predictors of the ADL-Q Total. To isolate
effects of cognition, the orientation scorewas not included in
the model.Abbreviations:N, 448; ADL-Q, Activities of Daily Living Questionnaire;
MoCA, Montreal Cognitive Assessment.
NOTE. Beta coefficients presented are for the MoCA total score. All
models also fit age, education, gender, and estimated intelligence in addition
to the MoCA total. All R2 change statistics and all regression coefficients
significant at the P , .001 level.3. Results
MoCA and ADL-Q scores for the entire sample are listed
in Table 1 along with associated correlations. The mean total
MoCA score was 20.2 (SD 5 5.11), and the mean ADL-Q
total was 27.9 (SD5 18.6). The Pearson correlation between
total scores was weak-to-moderate (r 5 20.34; P , .001),
such that lower MoCA scores were associated with higher
levels of functional impairment in ADLs.
R2 and associated R2 change values obtained from adding
the MoCA total score to each base model are reported in
Table 2, along with standardized regression coefficients
and confidence intervals. For each model fit, adding the
MoCA significantly increased the proportion of variance ac-
counted for above and beyond demographic factors alone.
The visuospatial/executive domain of the MoCA was the
cognitive domain most predictive of ADL-Q total score
(b 5 20.25, P 5 ,.001), followed by attention
(b 5 20.13, P 5 , .001), language (b 5 20.11, P 5
,.001), and delayed recall (b520.085, P5 .001). Naming
and abstraction domain scores were not significant predic-
tors of ADL-Q total score. Owing to listwise exclusion,
the sample size for the model including individual MoCA
domains was reduced (see Table 1).Table 1
Test means, standard deviations, and ADL-Q correlation with MoCA total
score
Test Domain Mean (SD) N r
ADL-Q domain
Total score 27.90 (18.61) 448 20.34
Self-care 11.40 (13.27) 448 20.27
Household care 32.78 (30.06) 448 20.21
Employment/recreation 44.89 (25.49) 448 20.19
Shopping/money 31.32 (32.44) 448 20.35
Travel 32.78 (28.07) 448 20.29
Communication 26.10 (19.26) 448 20.37
MoCA domain
Total score 20.15 (5.11) 448
Visuospatial/executive 3.42 (1.33) 411
Naming 2.69 (.58) 411
Attention 4.70 (1.44) 411
Language 1.84 (.93) 411
Abstraction 1.28 (.82) 411
Delayed recall 1.36 (1.57) 411
NOTE. r5 Pearson correlation with MoCA total score. All r coefficients
significant at P , .001.4. Discussion
In an outpatient neurology clinic population, there is a
weak-to-moderate inverse relationship between perfor-
mance on the MoCA and ADL-Q such that individuals
with lower MoCA scores are more likely to have impair-
ment in ADLs. These findings add to previous research
demonstrating the relationship between cognitive
screening measures and functional status (i.e., MMSE
and ADL-Q) [6] and the larger body of research demon-
strating the association between cognition and everyday
functioning in the elderly [13]. For each functional
domain, integrating the MoCA improved characterization
of functional status above and beyond simple demo-
graphic variables. Reviewing the individual standardized
regression coefficients finds that financial management
was most sensitive to changes in MoCA scores, and
participation in employment and recreational activities
was the least sensitive. Of the six MoCA domains exam-
ined, the visuospatial/executive functioning domain was
the most predictive of functional ability, which is consis-
tent with previous research highlighting the importance of
executive functioning in ADLs [5]. This finding provides
further evidence of the added utility of the MoCA over
other cognitive screening measures that do not include a
measure of executive functioning.
A limitation of the present study is that the sample is
somewhat diverse from a diagnostic standpoint and pre-
cise diagnostic information was not available for all indi-
viduals. The advantage of the present sample, however, is
that the clinical heterogeneity is more likely to reflect
that seen in a typical outpatient setting, increasing the
generalizability of these findings. Future directions
should evaluate the relationship between the MoCA
and ADL-Q in specific disease populations. Although
diagnostic considerations were available in the present
data set, both the MoCA and the ADL-Q were used in
the clinical decision-making process, thus preventing
more refined study of specific patient groups with the
present data set.
J. Durant et al. / Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 4 (2016) 43-4646Among older adults, especially those presenting for
memory complaints, cognitive screening should be a routine
component of the neurological examination. The MoCA is
one such option that has the added sensitivity to executive
dysfunction. Given the present findings, low scores on the
MoCA should raise concerns about functional decline and
prompt for more in-depth functional assessment as part of
comprehensive neuropsychological testing.RESEARCH IN CONTEXT
1. Systematic review: The authors reviewed the litera-
ture on the association between cognitive screening
measures, including the MMSE and MoCA and
measures of activities of daily living (ADL), using
traditional sources (e.g., PubMed).
2. Interpretation: Lower MoCA scores were associated
with higher levels of functional impairment in ADLs.
For each functional domain, integrating the MoCA
improved characterization of functional status above
and beyond simple demographic variables. The vi-
suospatial/executive functioning domain was the
most predictive of functional ability. These results
highlight the importance of executive functioning
in ADLs and provide further evidence of the added
utility of the MoCA over other cognitive screening
measures that do not include a measure of executive
functioning.
3. Future directions: The present study is limited by a
heterogeneous clinical sample. Future directions for
research should include evaluation of the relationship
between the MoCA and ADL-Q in specific disease
populations.References
[1] Millan-Calenti JC, Tubio J, Pita-Fernandez S, Rochette S,
Lorenzo T, Maseda A. Cognitive impairment as predictor of func-
tional dependence in an elderly sample. Arch Gerontol Geriatr
2012;54:197–201.
[2] Solomon TM, deBros GB, Budson AE, Mirkovic N, Murphy CA,
Solomon PR. Correlational analysis of 5 commonly used measures
of cognitive functioning and mental status: an update. Am J Alz-
heimers Dis Other Demen 2014;29:718–22.
[3] Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E. The con-
sortium to establish a registry for alzheimer’s disease (CERAD): Part
XI. Clinical milestones in patients with alzheimer’s disease followed
over 3 years. Neurology 1995;45:1451–5.
[4] Sikkes SA, de Rotrou J. A qualitative review of instrumental activities
of daily living in dementia: what’s cooking? Neurodegener Dis Manag
2014;4:393–400.
[5] Martyr A, Clare L. Executive function and activities of daily living in
Alzheimer’s disease: a correlational meta-analysis. Dement Geriatr
Cogn Disord 2012;33:189–203.
[6] Johnson N, Barion A, Rademaker A, Rehkemper G, Weintraub S. The
Activities of Daily Living Questionnaire: a validation study in patients
with dementia. Alzheimer Dis Assoc Disord 2004;18:223–30.
[7] Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A prac-
tical method for grading the cognitive state of patients for the clinician.
J Psychiatr Res 1975;12:189–98.
[8] Morris JC. Clinical dementia rating: a reliable and valid diagnostic and
staging measure for dementia of the Alzheimer type. Int Psychogeriatr
1997;9:173–6. discussion 177–178.
[9] Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S,
Whitehead V, Collin I, et al. The Montreal Cognitive Assessment,
MoCA: a brief screening tool for mild cognitive impairment. J Am
Geriatr Soc 2005;53:695–9.
[10] Freitas S, Simoes MR, Alves L, Santana I. Montreal cognitive assess-
ment: validation study for mild cognitive impairment and Alzheimer
disease. Alzheimer Dis Assoc Disord 2013;27:37–43.
[11] Larner AJ. Screening utility of the Montreal Cognitive Assessment
(MoCA): in place of–or as well as–the MMSE? Int Psychogeriatr
2012;24:391–6.
[12] Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE.
Comparative accuracies of two common screening instruments for
classification of Alzheimer’s disease, mild cognitive impairment,
and healthy aging. Alzheimers Dement 2013;9:529–37.
[13] Barberger-Gateau P, Fabrigoule C. Disability and cognitive impair-
ment in the elderly. Disabil Rehabil 1997;19:175–93.
